Nguyen Xuan Mui, one of the major shareholders of DDB Pharmaceutical Joint Stock Company, has officially ceased to hold this position after transferring most of his shares. According to reports, he has reduced his ownership stake to below 5%, resulting in the loss of his major shareholder status. This information was disclosed in DDB’s financial statements, attracting attention from investors and shareholders alike. With this change, shareholders and investors are closely monitoring changes in the shareholder structure and the potential impacts on DDB’s operations and development direction in the future.
Leave a Reply